Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Researchers identify possible treatment targets for myelodysplasia syndromes

Researchers identify possible treatment targets for myelodysplasia syndromes

UC researchers uncover obesity-related protein's role in leukemia development

UC researchers uncover obesity-related protein's role in leukemia development

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

New technology that increases Natural Killer cells to stop cancers gets licensed

New technology that increases Natural Killer cells to stop cancers gets licensed

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Simple, coordinated approach can improve chances of survival for high-risk AML patients

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New study finds smoking cessation at any age reduces risk of death

New study finds smoking cessation at any age reduces risk of death

Cancer gene mutations can predict response to less intensive treatment in AML patients

Cancer gene mutations can predict response to less intensive treatment in AML patients

Implementation of large-scale genomic tumor profiling viable but faces several challenges

Implementation of large-scale genomic tumor profiling viable but faces several challenges

ASH partners with other organizations to address knowledge gaps in AML care

ASH partners with other organizations to address knowledge gaps in AML care

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Nano-biointeraction and nanopathology

Nano-biointeraction and nanopathology

Blocking critical molecule with therapeutic antibody could effectively reduce leukemia burden

Blocking critical molecule with therapeutic antibody could effectively reduce leukemia burden

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

New oncogene may contribute to high incidence of prostate cancer among African American men

New oncogene may contribute to high incidence of prostate cancer among African American men